What Researchers Did
The researchers looked back at records of women with long-lasting breast inflammation (refractory idiopathic granulomatous mastitis, or IGM) and compared those who took only steroids with those who took steroids plus hyperbaric oxygen therapy (HBOT).
What They Found
In this retrospective cohort study of refractory IGM patients at three tertiary care centers, recovery results were similar in the steroid-only group and the HBOT plus steroid group, while the steroid-only group used a higher daily steroid dose for longer (16 mg vs. 4 mg and 270 days vs. 30 days, p less than 0.001). The study ran from January 2021 to July 2023. The groups did not differ much in their demographic and clinical features. Multicentric disease was more common in the HBOT group (66.67 percent, p = 0.044).
What This Means for Canadian Patients
For people with refractory IGM, this study found similar recovery in both groups, with lower steroid dose and shorter steroid use in the group that also received HBOT. Because patients were not randomly assigned, the study cannot show that HBOT caused the lower steroid use. The abstract does not report HBOT pressure or session numbers.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a retrospective study without random assignment, and the authors say it needs support from prospective studies that look at cost effectiveness and possible long term complications.